Securities code: Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) Announcement No.: 2022017
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317)
Announcement on the resolution of the 17th meeting of the seventh board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) (hereinafter referred to as “the company”) the notice of the 17th meeting of the seventh board of directors was delivered to all directors by hand and e-mail on February 22, 2022, and the meeting was held in the company’s conference room on March 1, 2022 by on-site and communication voting. There are 9 directors who should attend the meeting, and 9 actually attended the meeting. The meeting was presided over by Mr. Chen Yonghong, chairman of the company, and all supervisors and the Secretary of the board of directors attended the meeting as nonvoting delegates. The convening and convening of this meeting comply with the relevant provisions of laws, regulations and the articles of association. After careful deliberation and voting by open ballot, the directors present at the meeting made the following resolutions:
1、 The proposal on adjusting the list of incentive objects and the number of awards of the company’s restricted stock incentive plan in 2022 was reviewed and approved.
Two incentive objects resigned for personal reasons and no longer have incentive qualification. According to the relevant provisions of the company’s 2022 restricted stock incentive plan (Draft) and the authorization of the company’s first extraordinary general meeting in 2022, the board of directors agreed to cancel its qualification to participate in the 2022 restricted stock incentive plan. In 2022, the incentive objects of the restricted stock incentive plan will be adjusted from 79 to 77, and the total number of restricted shares granted will be adjusted from 5840000 shares to 5780000 shares.
In addition to the above adjustments, other contents of the restricted stock incentive plan implemented by the company this time are consistent with the company’s 2022 restricted stock incentive plan (Draft) approved by the company’s first extraordinary general meeting in 2022. Voting results: 9 in favor, 0 against and 0 abstention.
Note: the announcement on adjusting the list of incentive objects and the number of awards of the company’s restricted stock incentive plan in 2022 and the list of incentive objects of the restricted stock incentive plan in 2022 (after adjustment) are detailed in the information disclosure media: Securities Times and http://www.cn.info.com.cn.
Securities code: Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) Announcement No.: 2022017
2、 The proposal on granting restricted shares to the incentive objects of the company’s restricted stock incentive plan in 2022 was reviewed and approved.
According to the measures for the administration of equity incentive of listed companies, the company’s 2022 restricted stock incentive plan (Draft) and other relevant provisions and the authorization of the company’s first extraordinary general meeting in 2022, the board of Directors considers that the grant conditions specified in the company’s incentive plan have been met, and agrees to take March 1, 2022 as the grant date, with the grant price of 5.58 yuan / share, 5780000 restricted shares were granted to 77 incentive objects.
The independent directors of the company have expressed their independent opinions on the matter; The board of supervisors of the company issued verification opinions on the list of incentive objects granted by the restricted stock incentive plan.
Voting results: 9 in favor, 0 against and 0 abstention.
Note: the announcement on granting restricted shares to the incentive objects of the company’s restricted stock incentive plan in 2022 is detailed in the information disclosure media: Securities Times and cninfo (www.cn. Info. Com. CN). Documents for future reference
Resolutions of the board of directors signed and sealed by the directors present at the meeting.
It is hereby announced.
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) board of directors March 1, 2002
